Exosens 9M 2026 Adjusted Gross Margin Rises 16% to €194.9 Million

Exosens posted 9M 2026 revenue of €386.9M, up 18.0% YoY, with Q3 growth accelerating to 23.5%. Adjusted gross margin was €194.9M (50.4%). The company says it is on track to meet its upgraded 2026 guidance.Material DetailsContext by AI AnalystThis is a mid-cycle confirmation of accelerating demand a…